PneumoWave develops real-time monitoring solutions for respiratory conditions, allowing patients and doctors to track respiratory rates and performance outside of hospital settings. Their proprietary sensor technology and AI-driven software platform enable doctors to optimize medication use, detect early signs of deterioration, reduce hospital admissions, and minimize in-person appointments. With a focus on reducing deaths and preventing hospital stays, PneumoWave's digital therapeutics provide real-time physiological data and patient-centric digital biomarkers, enabling healthcare professionals to closely monitor patients remotely. The company holds pending patents in the US and UK and more information can be found on their website.